Results 71 to 80 of about 166,748 (266)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Mapping the Scientific Outputs of Allameh Tabataba'i University from 1974 to 2024 [PDF]

open access: yesبازیابی دانش و نظام‌های معنایی
IntroductionScientific outputs that report on the findings of scientific research play a crucial role in enhancing knowledge, advancing science, and promoting research within academic communities.
Seyed Mahdi Taheri, Negin Shokrzadeh
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Scientific Outputs Regarding Occupational Health among Female Workers

open access: yesInternational Journal of Occupational Hygiene, 2015
Although the International Labor Organization (ILO) has reported that two-thirds of the world’s occupations belong to women, a few studies regarding employed women have been conducted.
MARYAM NIKPOUR   +2 more
doaj  

Comparison between Iranian health scientific outputs and disease burden [PDF]

open access: yesمجله علم‌سنجی کاسپین, 2019
Background and aim: One of the most important infrastructures for the development and progress of countries is scientific outputs and targeted research to meet the needs of society and reduce the disease burden. The aim of this study was to determine the
Arezoo Ghamgosar   +3 more
doaj  

Presenting A Paradigm Model for the Effect of Educational and Research Interactions Between Faculty Members, Students, and Librarians on Scientific Outputs Using a Grounded Theory Approach [PDF]

open access: yesنشریه مطالعات دانش‌پژوهی
Purpose: This study aimed to develop a model illustrating the impact of research interactions among faculty members, students, and librarians on scientific outputs, employing a grounded theory approach.Methodology: This qualitative research utilized a ...
Safiyeh tahmasebi Limooni
doaj   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy